Optimal Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$2.28M Buy
8,667
+13
+0.2% +$3.56K 0.29% 131
2021
Q2
$2.13M Hold
8,654
0.25% 145
2021
Q1
$1.68M Buy
8,654
+314
+4% +$63K 0.22% 162
2020
Q4
$1.77M Sell
8,340
-22
-0.3% -$4.39K 0.25% 137
2020
Q3
$1.43M Sell
8,362
-163
-2% -$30.1K 0.21% 163
2020
Q2
$1.64M Sell
8,525
-10,694
-56% -$1.75M 0.27% 135
2020
Q1
$2.83K Buy
19,219
+8,590
+81% +$1.37M 0.27% 128
2019
Q4
$1.65M Buy
+10,629
New +$1.53M 0.25% 152

Other funds holding RMD

Optimal Asset Management's RMD Position: Q3 2021 in Review

Optimal Asset Management increased its ResMed (RMD) stake by 0.15% in Q3 2021, buying an estimated $3.56K and bringing the position to 8,667 shares worth $2.28M. The position accounts for 0.29% of the portfolio, ranked #131.

Optimal Asset Management first reported a position in RMD in Q4 2019 and has held it in 8 quarters since. 686 funds tracked by Wall St. Rank hold RMD as of Q3 2021.

  • Optimal Asset Management held 8,667 shares of ResMed worth $2.28M as of Q3 2021.
  • Optimal Asset Management bought 13 ResMed shares in Q3 2021, an estimated $3.56K.
  • ResMed made up 0.29% of Optimal Asset Management's portfolio in Q3 2021, its #131 holding.
  • Optimal Asset Management first reported a position in ResMed in Q4 2019 and has held it in 8 quarters since.
  • 686 funds tracked by Wall St. Rank held ResMed as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.